Potential Pharmacokinetic Drug⁻Drug Interaction Between Harmine, a Cholinesterase Inhibitor, and Memantine, a Non-Competitive


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
11 Apr 2019
Historique:
received: 18 03 2019
revised: 09 04 2019
accepted: 10 04 2019
entrez: 14 4 2019
pubmed: 14 4 2019
medline: 1 8 2019
Statut: epublish

Résumé

Harmine (HAR) is a beta-carboline alkaloid widely distributed in nature. It exhibits psychopharmacological effects of improving learning and memory. However, excessive dose of HAR can cause central tremor toxicity, which may be related to the glutamate system. Memantine (MEM) is a non-competitive

Identifiants

pubmed: 30978991
pii: molecules24071430
doi: 10.3390/molecules24071430
pmc: PMC6479946
pii:
doi:

Substances chimiques

Cholinesterase Inhibitors 0
Receptors, N-Methyl-D-Aspartate 0
Harmine 4FHH5G48T7
Memantine W8O17SJF3T

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : the National Nature Science Foundation of China
ID : 81872933
Organisme : the National Natural Science Foundation of China and Xinjiang Uygur Autonomous Region of China
ID : U1130303
Organisme : the Key Project of Ministry of Science and Technology of China
ID : 2017ZX09301068-004-001

Références

J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Feb 1;1074-1075:25-33
pubmed: 29329092
Neurosci Lett. 1985 Apr 9;55(2):179-84
pubmed: 2582318
Pharmacol Res. 2005 Jan;51(1):1-17
pubmed: 15519530
Arch Biochem Biophys. 2000 Sep 15;381(2):191-204
pubmed: 11032406
Drug Metab Dispos. 2010 Sep;38(9):1464-70
pubmed: 20522662
J Pharmacol Exp Ther. 2003 Apr;305(1):315-22
pubmed: 12649384
Parkinsonism Relat Disord. 2008;14 Suppl 2:S189-93
pubmed: 18579428
Exp Brain Res. 1973 Aug 31;18(1):69-87
pubmed: 4746753
Brain Res. 1973 Apr 13;53(1):81-95
pubmed: 4697252
Handb Exp Pharmacol. 2010;(199):19-48
pubmed: 20204582
Expert Opin Drug Metab Toxicol. 2013 Mar;9(3):237-52
pubmed: 23256482
Drug Metab Dispos. 2018 Jun;46(6):913-923
pubmed: 29650790
J Pharm Biomed Anal. 2015 Nov 10;115:283-91
pubmed: 26263056
Front Pharmacol. 2017 Aug 21;8:541
pubmed: 28871225
Am J Alzheimers Dis Other Demen. 2005 Mar-Apr;20(2):77-85
pubmed: 15844753
Food Chem. 2012 Sep 15;134(2):1096-105
pubmed: 23107733
Molecules. 2016 Sep 15;21(9):
pubmed: 27649128
Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003154
pubmed: 16625572
Eur J Pharmacol. 2015 Dec 5;768:96-107
pubmed: 26526348
Proc Natl Acad Sci U S A. 1990 Jul;87(13):5051-5
pubmed: 2367523
Clin Pharmacokinet. 2007;46(7):599-612
pubmed: 17596105
Clin Pharmacokinet. 2013 Apr;52(4):225-41
pubmed: 23408070
Oncotarget. 2015 Apr 20;6(11):8988-9001
pubmed: 25940702
Case Rep Emerg Med. 2014;2014:783236
pubmed: 24955262
Pharm Biol. 2016 Sep;54(9):1768-81
pubmed: 26730489
Neuropharmacology. 2007 Nov;53(6):699-723
pubmed: 17904591
J Pharm Sci. 1977 Sep;66(9):1244-8
pubmed: 903860
Neurosci Biobehav Rev. 1997 Jul;21(4):393-400
pubmed: 9195597
Mol Pharmacol. 1998 Aug;54(2):342-52
pubmed: 9687576
Physiol Behav. 2015 Jan;138:260-5
pubmed: 25250831
Exp Brain Res. 2002 Aug;145(4):457-67
pubmed: 12172657
J Ethnopharmacol. 2015 Jun 20;168:279-86
pubmed: 25862961
Neuropharmacology. 2010 Sep-Oct;59(4-5):221-9
pubmed: 20156462
Brain Res. 1976 Jan 23;101(3):461-78
pubmed: 128400
Clin Pharmacokinet. 2002;41(10):719-39
pubmed: 12162759
Brain Res Mol Brain Res. 2005 Mar 24;134(1):57-66
pubmed: 15790530
PLoS Curr. 2011 Dec 15;3:RRN1291
pubmed: 22307216
Food Chem Toxicol. 2010 Mar;48(3):839-45
pubmed: 20036304
Neuropharmacology. 1999 Jun;38(6):735-67
pubmed: 10465680
CNS Drugs. 2002;16(12):811-24
pubmed: 12421115
Toxicol In Vitro. 1998 Dec;12(6):715-23
pubmed: 20654461
Phytother Res. 2011 Nov;25(11):1671-7
pubmed: 21433154
Lancet. 2005 Dec 17;366(9503):2112-7
pubmed: 16360788
Front Pharmacol. 2018 Apr 10;9:346
pubmed: 29755345
Curr Opin Pharmacol. 2006 Feb;6(1):61-7
pubmed: 16368266
J Pharmacol Exp Ther. 2003 Sep;306(3):821-7
pubmed: 12805474
Cereb Cortex. 2013 Sep;23(9):2179-89
pubmed: 22791805
J Ethnopharmacol. 2017 May 5;203:127-162
pubmed: 28359849
Toxicol Appl Pharmacol. 2004 Sep 15;199(3):285-94
pubmed: 15364544
J Neural Transm (Vienna). 2010 Oct;117(10):1131-7
pubmed: 20686906
Acta Pharmacol Sin. 2019 Feb;40(2):288-296
pubmed: 29773886
Drug Test Anal. 2017 May;9(5):754-768
pubmed: 27377954
J Neural Transm (Vienna). 2006 Nov;113(11):1671-7
pubmed: 17053873

Auteurs

Yunpeng Zhang (Y)

The MOE Key Laboratory for Standardization of Chinese Medicines and The SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Rood, Shanghai 201203, China. zhangyp1028@163.com.

Shuping Li (S)

The MOE Key Laboratory for Standardization of Chinese Medicines and The SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Rood, Shanghai 201203, China. lishupinghappy@163.com.

Youxu Wang (Y)

The MOE Key Laboratory for Standardization of Chinese Medicines and The SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Rood, Shanghai 201203, China. wyxzd1314@163.com.

Gang Deng (G)

The MOE Key Laboratory for Standardization of Chinese Medicines and The SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Rood, Shanghai 201203, China. 18930900232@163.com.

Ning Cao (N)

The MOE Key Laboratory for Standardization of Chinese Medicines and The SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Rood, Shanghai 201203, China. 18616024782@163.com.

Chao Wu (C)

The MOE Key Laboratory for Standardization of Chinese Medicines and The SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Rood, Shanghai 201203, China. vera105370@163.com.

Wenzheng Ding (W)

The MOE Key Laboratory for Standardization of Chinese Medicines and The SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Rood, Shanghai 201203, China. 18817385708@163.com.

Yuwen Wang (Y)

The MOE Key Laboratory for Standardization of Chinese Medicines and The SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Rood, Shanghai 201203, China. wangyuwen92@163.com.

Xuemei Cheng (X)

The MOE Key Laboratory for Standardization of Chinese Medicines and The SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Rood, Shanghai 201203, China. chengxuemei1963@163.com.
Shanghai R&D Centre for Standardization of Chinese Medicines, 1200 Cailun Rood, Shanghai 201203, China. chengxuemei1963@163.com.

Changhong Wang (C)

The MOE Key Laboratory for Standardization of Chinese Medicines and The SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Rood, Shanghai 201203, China. wchcxm@hotmail.com.
Shanghai R&D Centre for Standardization of Chinese Medicines, 1200 Cailun Rood, Shanghai 201203, China. wchcxm@hotmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH